CA45422-3A - 0x00000000000067A6

Healthy Males & Females

Alchemy

* Stipend may pay up to reflected amount.
Start Date: 
November 6, 2025 - 7:30am
End Date: 
February 26, 2026 - 8:00am

Study Details

Study Number: CA45422
Group Number: 3A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,500.00

Study Criteria

Age: 19 - 65
BMI: 18 - 32
Weight Restriction: minimum weight 110 lbs

Study Information

Indication: This investigational medication is being developed to treat ALS (often called Lou Gehrig's disease) which causes muscle weakness and paralysis.
Route of Administration: Injection IV infusion
Blood Draws: 22

Study Schedule

Schedule Type: Short stays with returns
Study Length: 4- Night Stay, 6 Returns & 1 Phone Call

Screening Dates (appointments available in Lincoln and Omaha):

Event Day Event Date
Friday 10/24/2025
Friday 10/31/2025
Monday 11/3/2025

Doctor Exam Dates (appointments available in Lincoln and Omaha):

Event Day Event Date
Friday 10/24/2025
Friday 10/31/2025
Monday 11/3/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Return Thursday 11/6/2025 7:30:00 AM Thursday 11/6/2025 8:30:00 AM 1L Lincoln
Check-In Wednesday 11/12/2025 1:30:00 PM Sunday 11/16/2025 8:00:00 AM 1 Lincoln
Phone participant Thursday 11/20/2025 11:00:00 AM 1 Lincoln
Return Wednesday 11/26/2025 7:00:00 AM Wednesday 11/26/2025 8:00:00 AM 1 Lincoln
Return Wednesday 12/10/2025 7:00:00 AM Wednesday 12/10/2025 8:00:00 AM 1 Lincoln
Return Friday 1/9/2026 7:00:00 AM Friday 1/9/2026 8:00:00 AM 1 Lincoln
Return Thursday 1/29/2026 7:00:00 AM Thursday 1/29/2026 8:00:00 AM 1 Lincoln
Return Thursday 2/26/2026 7:00:00 AM Thursday 2/26/2026 8:00:00 AM 1 Lincoln